What Researchers Did
Researchers presented 6 cases of patients with paroxysmal sympathetic hyperactivity (PSH) after severe traumatic brain injury who received hyperbaric oxygen therapy (HBOT) after conventional medications had limited success.
What They Found
In all 6 reported cases of severe traumatic brain injury patients experiencing paroxysmal sympathetic hyperactivity (PSH), hyperbaric oxygen therapy (HBOT) successfully controlled paroxysmal autonomic changes and posturing. This control was observed in the early subacute phase, following limited success with conventional medication regimens for these 6 patients.
What This Means for Canadian Patients
For Canadian patients experiencing paroxysmal sympathetic hyperactivity (PSH) after severe traumatic brain injury, hyperbaric oxygen therapy (HBOT) could be a potential treatment option. This may be particularly relevant if standard pharmacologic management proves insufficient in controlling their symptoms.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian participants or researchers.
Study Limitations
As a case report involving only 6 patients, this study's findings are limited by its small sample size and lack of a control group, preventing generalization of results.